Entry |
|
Name |
Lenrispodun (USAN) |
Formula |
C29H26FN7O
|
Exact mass |
507.2183
|
Mol weight |
507.56
|
Structure |

|
Remark |
|
Efficacy |
Antiparkinsonian, Phosphodiesterase 1 inhibitor |
Comment |
Treatment of Parkinson's disease, cardiovascular diseases, and other neurological and cardiovascular diseases
|
Target |
|
Brite |
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE1
D11883 Lenrispodun (USAN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 38
1 N4y N 16.2283 -20.0670
2 C8y C 16.2283 -21.4652
3 N4y N 17.4167 -22.1642
4 C8y C 18.6750 -21.4652
5 C8y C 18.6750 -20.0670
6 C8y C 17.4167 -19.3680
7 C1a C 17.4167 -23.5623
8 O5x O 19.8634 -22.1642
9 C8y C 19.7236 -19.1583
10 N4y N 19.0945 -17.8301
11 N5x N 17.6964 -17.9699
12 N1b N 20.9120 -19.8573
13 C8y C 22.1004 -19.1583
14 C8x C 23.2888 -19.8573
15 C8x C 24.5471 -19.1583
16 C8x C 24.5471 -17.7601
17 C8x C 23.3587 -17.0611
18 C8x C 22.1004 -17.7601
19 C1b C 20.2829 -17.1310
20 C8y C 20.2829 -15.7329
21 C8x C 21.4936 -15.0338
22 C8x C 21.4936 -13.6357
23 C8y C 20.2829 -12.9365
24 C8x C 19.0721 -13.6357
25 C8x C 19.0721 -15.0338
26 C8y C 20.2829 -11.5384
27 N5x N 21.4936 -10.8394
28 C8y C 21.4936 -9.4412
29 C8x C 20.2829 -8.7422
30 C8x C 19.0721 -9.4412
31 C8x C 19.0721 -10.8394
32 X F 22.6875 -8.7518
33 C1y C 14.8986 -19.6350
34 C1y C 14.0768 -20.7661
35 N2x N 14.8986 -21.8972
36 C1x C 14.0768 -18.5038
37 C1x C 12.7470 -18.9360
38 C1x C 12.7470 -20.3341
BOND 44
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 3 7 1
8 4 8 2
9 5 9 2
10 9 10 1
11 10 11 1
12 6 11 2
13 9 12 1
14 12 13 1
15 13 14 2
16 14 15 1
17 15 16 2
18 16 17 1
19 17 18 2
20 13 18 1
21 19 10 1
22 19 20 1
23 20 21 2
24 21 22 1
25 22 23 2
26 23 24 1
27 24 25 2
28 20 25 1
29 23 26 1
30 26 27 2
31 27 28 1
32 28 29 2
33 29 30 1
34 30 31 2
35 26 31 1
36 28 32 1
37 1 33 1
38 33 34 1
39 34 35 1
40 2 35 2
41 33 36 1
42 36 37 1
43 37 38 1
44 34 38 1
|